Peder M.
- Country
- Norway
- Department
- Hjertemedisinsk avdeling
Research Overview
- Randomized Comparative Evaluation of Ticagrelor, Prasugrel, and Aspirin/Dipyridamole Combination Therapy for Antiplatelet Management in Acute Coronary Syndrome
- Evaluation of Inclisiran's Efficacy in Reducing Major Adverse Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Mavacamten in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy: A Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 303 of 985 partner sites.
Specializations
Cardiovascular Disease Management
This investigator specializes in the treatment of atherosclerotic cardiovascular disease (ASCVD), with particular emphasis on preventive cardiology and lipid management. Their research explores innovative therapeutic approaches for reducing cardiovascular events in high-risk patients.
- Cardiovascular Risk Reduction
- Lipid Management
- Preventive Cardiology
Their work focuses on exploring treatments for patients with established vascular disease requiring additional interventional approaches.
Cardiac Structure Disorders
The investigator conducts research in non-obstructive hypertrophic cardiomyopathy, investigating therapeutic solutions that address both the structural and functional aspects of the condition. Their work emphasizes improving patient quality of life and functional capacity.
- Cardiomyopathy Treatment
- Exercise Capacity Enhancement
- Symptom Management
The research encompasses comprehensive evaluation of cardiac function and patient-reported outcomes in cardiomyopathy.
Metabolic Health
This investigator studies the intersection of obesity and cardiovascular health, examining therapeutic approaches that address both metabolic and cardiovascular outcomes. Their research explores the relationship between weight management and cardiovascular risk factors.
- Obesity Management
- Cardiovascular Safety
- Metabolic Risk Assessment
The focus includes evaluation of novel treatments for obesity with particular attention to cardiovascular safety profiles.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.